Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04737590` - Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts	N/A
Completed	`NCT03076138` - Gene-activated Bone Substitute for Maxillofacial Bone Regeneration	N/A
Withdrawn	`NCT00459641` - Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts	Phase 2
Recruiting	`NCT05880628` - Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts

See also

Status

Clinical Trial

Phase

Recruiting

NCT04737590 - Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts

N/A

Completed

NCT03076138 - Gene-activated Bone Substitute for Maxillofacial Bone Regeneration

N/A

Withdrawn

NCT00459641 - Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

Phase 2

Recruiting

NCT05880628 - Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05075148
Study type	Observational
Source	University Hospital, Montpellier
Contact
Status	Enrolling by invitation
Phase
Start date	January 1, 2021
Completion date	March 30, 2022

Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment — KOA-RI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms